Showing results (41-50 of 350) with videos related to
Sort By:
Pageof 35
Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1993
Dystonia in central pontine myelinolysis without evidence of extrapontine myelinolysisS M Salerno, R Kurlan, S E Joy, et al.Journal of Clinical and Experimental Neuropsychology|September 1, 1993
Assessment of intellectual function in dementing disorders: validity of WAIS-R short forms for patients with Alzheimer's, Huntington's, and Parkinson's diseaseC Randolph, E Mohr, T N ChaseAdvances in Neurology|January 1, 1983
On-off effects in Parkinson's disease: a controlled investigation of ascorbic acid therapyD K Reilly, L Hershey, L Rivera-Calimlim, et al.Neurologic Clinics|May 1, 1996
Clinical research in neurology. From observation to experimentationF J Marshall, K Kieburtz, M McDermott, et al.Archives of Internal Medicine|April 1, 1976
Reversal of systemic manifestations of cryoglobulinemia. Treatment with melphalan and prednisoneS C Ristow, P F Griner, G N Abraham, et al.Brain Research|July 5, 1988
Atrophy of medium spiny I striatal dendrites in advanced Parkinson's diseaseT H McNeill, S A Brown, J A Rafols, et al.Annals of Clinical and Laboratory Science|January 1, 1976
Biochemical aids in the diagnosis of Parkinson's diseaseT N Chase, N Eng, E K GordonNeurology|October 1, 1976
Intravenous probenecid loading. Effects on plasma and cerebrospinal fluid probenecid levels and on monoamine metabolites in cerebrospinal fluidR Kartzinel, M H Ebert, T N ChaseEuropean Journal of Pharmacology|March 19, 1991
Effect of Gi protein ADP-ribosylation induced by pertussis toxin on dopamine-mediated behaviorsC Marin, S A Parashos, T N ChaseMovement Disorders : Official Journal of the Movement Disorder Society|October 2, 1998
Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeysP J Blanchet, S Konitsiotis, T N ChasePageof 35